Rafferty Asset Management LLC Buys Shares of 89,126 908 Devices Inc. (NASDAQ:MASS)

Rafferty Asset Management LLC bought a new stake in 908 Devices Inc. (NASDAQ:MASS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 89,126 shares of the company’s stock, valued at approximately $3,454,000. Rafferty Asset Management LLC owned about 0.32% of 908 Devices as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of MASS. Citigroup Inc. acquired a new stake in 908 Devices in the 1st quarter worth about $29,000. Royal Bank of Canada acquired a new position in 908 Devices during the 1st quarter valued at approximately $36,000. UBS Group AG bought a new stake in 908 Devices during the 1st quarter valued at $116,000. American International Group Inc. bought a new stake in shares of 908 Devices in the 1st quarter worth $204,000. Finally, Virtu Financial LLC bought a new stake in shares of 908 Devices in the 1st quarter worth $208,000. 42.24% of the stock is currently owned by institutional investors.

Shares of MASS stock opened at $35.99 on Wednesday. The firm has a 50 day moving average price of $33.69 and a two-hundred day moving average price of $41.48. The company has a quick ratio of 13.35, a current ratio of 14.06 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $995.09 million and a PE ratio of -29.02. 908 Devices Inc. has a 12-month low of $29.20 and a 12-month high of $79.60.

908 Devices (NASDAQ:MASS) last issued its quarterly earnings data on Tuesday, August 3rd. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.05). As a group, research analysts expect that 908 Devices Inc. will post -0.76 EPS for the current year.

In other 908 Devices news, CTO Christopher D. Brown sold 35,000 shares of the business’s stock in a transaction on Wednesday, July 7th. The shares were sold at an average price of $33.63, for a total transaction of $1,177,050.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Trent A. Basarsky sold 21,000 shares of the business’s stock in a transaction on Friday, July 23rd. The stock was sold at an average price of $32.25, for a total transaction of $677,250.00. Following the completion of the sale, the vice president now directly owns 47,000 shares in the company, valued at approximately $1,515,750. The disclosure for this sale can be found here. Over the last quarter, insiders sold 97,081 shares of company stock valued at $3,247,351. 51.10% of the stock is owned by company insiders.

MASS has been the subject of a number of analyst reports. Zacks Investment Research cut 908 Devices from a “hold” rating to a “sell” rating in a research report on Tuesday, August 10th. SVB Leerink reiterated a “buy” rating on shares of 908 Devices in a research note on Sunday, August 8th. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $68.00.

About 908 Devices

908 Devices Inc develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

Featured Story: Cost of Capital

Want to see what other hedge funds are holding MASS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 908 Devices Inc. (NASDAQ:MASS).

Institutional Ownership by Quarter for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.